|
|||||
|
|
New preclinical guidelines on drug effects on ventricular repolarization: safety pharmacology comes of age |
|
| Authors: | Kinter Lewis B Siegl Peter K S Bass Alan S |
| Affiliation: | Safety Assessment U.S., Development, AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437, USA. lewis.kinter@astrazeneca.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |